398 related articles for article (PubMed ID: 15985651)
21. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
22. Participation of prostaglandin E receptor EP4 subtype in duodenal bicarbonate secretion in rats.
Aoi M; Aihara E; Nakashima M; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G96-103. PubMed ID: 15194560
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells.
Elberg D; Turman MA; Pullen N; Elberg G
Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):11-6. PubMed ID: 22503965
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5'-monophosphate-mediated signaling pathways.
Gerlo S; Verdood P; Gellersen B; Hooghe-Peters EL; Kooijman R
J Immunol; 2004 Nov; 173(10):5952-62. PubMed ID: 15528329
[TBL] [Abstract][Full Text] [Related]
25. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
[TBL] [Abstract][Full Text] [Related]
26. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
[TBL] [Abstract][Full Text] [Related]
27. Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2/PGE4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B.
Chen BC; Liao CC; Hsu MJ; Liao YT; Lin CC; Sheu JR; Lin CH
J Immunol; 2006 Jul; 177(1):681-93. PubMed ID: 16785567
[TBL] [Abstract][Full Text] [Related]
28. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling.
Gray T; Nettesheim P; Loftin C; Koo JS; Bonner J; Peddada S; Langenbach R
Mol Pharmacol; 2004 Aug; 66(2):337-46. PubMed ID: 15266025
[TBL] [Abstract][Full Text] [Related]
30. Hypotonicity-induced Renin exocytosis from juxtaglomerular cells requires aquaporin-1 and cyclooxygenase-2.
Friis UG; Madsen K; Svenningsen P; Hansen PB; Gulaveerasingam A; Jørgensen F; Aalkjaer C; Skøtt O; Jensen BL
J Am Soc Nephrol; 2009 Oct; 20(10):2154-61. PubMed ID: 19628672
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP.
Aronoff DM; Canetti C; Peters-Golden M
J Immunol; 2004 Jul; 173(1):559-65. PubMed ID: 15210817
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation.
Miyamoto M; Ito H; Mukai S; Kobayashi T; Yamamoto H; Kobayashi M; Maruyama T; Akiyama H; Nakamura T
Osteoarthritis Cartilage; 2003 Sep; 11(9):644-52. PubMed ID: 12954235
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
Echeverria V; Clerman A; Doré S
Eur J Neurosci; 2005 Nov; 22(9):2199-206. PubMed ID: 16262658
[TBL] [Abstract][Full Text] [Related]
34. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG
Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E2 augments IL-10 signaling and function.
Cheon H; Rho YH; Choi SJ; Lee YH; Song GG; Sohn J; Won NH; Ji JD
J Immunol; 2006 Jul; 177(2):1092-100. PubMed ID: 16818766
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
37. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
39. Exocytosis and endocytosis in juxtaglomerular cells.
Friis UG; Jensen BL; Hansen PB; Andreasen D; Skøtt O
Acta Physiol Scand; 2000 Jan; 168(1):95-9. PubMed ID: 10691785
[TBL] [Abstract][Full Text] [Related]
40. [Prostaglandin E2 promotes hepatocellular carcinoma cell proliferation through EP2 prostanoid receptor].
Guo D; Chen NN; Hou LB; Lei LS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1564-7. PubMed ID: 21945767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
